Canna~Fangled Abstracts

Cholesterol regulates cannabinoid analgesia through glycine receptors

By July 23, 2020 July 27th, 2020 No Comments

doi: 10.1016/j.neuropharm.2020.108242.

Online ahead of print.


Cholesterol plays vital roles in many central physiological and pathological processes. As a key component in the cell membrane, cholesterol can regulate a variety of ion channels, including ligand-gated ion channels (LGICs). However, relatively little is known about the molecular detail and in vivo consequence of cholesterol-LGIC interaction. Here, we reveal that membrane cholesterol depletion significantly inhibits the potentiating effects of dehydroxylcannabidiol (DH-CBD) on glycine-activated currents (IGly) in HEK 293T cells expressing α1/α3 glycine receptors (GlyRs). Simvastatin considerably decreases cholesterol levels and DH-CBD-induced potentiation of IGly in the spinal cord of mice. Simvastatin also significantly decreases DH-CBD analgesia in acute and chronic pain of mice. The cholesterol levels in the dorsal horn of spinal cord, measured by mass spectrometry imaging, are specifically correlated with cannabinoid potentiation of spinal GlyRs and cannabinoid-induced analgesia. These findings suggest that spinal cholesterol is critical for the efficacy of glycinergic cannabinoid-induced analgesia.


Keywords: Analgesia, Cannabinoid, Cholesterol, Glycine receptor

Conflict of interest statement

Declaration of competing interest The authors have no conflicts of interest to declare.

Leave a Reply

en English